Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies and Federal Facilities Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 26, 2018
May 7, 2020
2b25a2e1-6aae-4b9c-a16b-579918ea3410
Related Documents
Compounding and Repackaging of Radiopharmaceuticals By Outsourcing Facilities Guidance for Industry
Guidance DocumentSeptember 26, 2018Center for Drug Evaluation and Research
Facility Definition Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentMay 10, 2018Center for Drug Evaluation and Research
Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentOctober 8, 2015Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox